Work on the next major amendment to the provisions of the Law on Reimbursement of Medicines, Foodstuffs for Special Dietary Purposes and Medical Devices enters another phase: on January 20 this year, information on the project was published in the list of legislative and program work of the...
The SNUR, or the announced rapid amendment to the Reimbursement Law, is not as quick as expected, however; for a finished draft of the law, whose primary purpose is to correct errors and remove the negative effects of last year's major amendment to the Law on Reimbursement of Medicines,...
Public consultations are currently underway on the next major amendment to the provisions of the Law on Reimbursement of Medicines, Foodstuffs for Special Dietary Purposes and Medical Devices, for which the acronym SNUR has already been adopted in the pharmaceutical market: rapid amendment of the...
In the heat of the discussion about the upcoming rapid revision of the Act on Reimbursement of Medicines, Foodstuffs for Special Dietary Purposes and Medical Devices (commonly referred to as SNUR), it is worthwhile to look at one of the biggest challenges facing the Polish health care system,...
Ministerstwo Zdrowia oficjalnie już zapowiedziało rozpoczęcie prac nad kolejną nowelizacją Ustawy o refundacji leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych. Zapowiedziana szybka nowelizacja Ustawy o refundacji (czyli tytułowy „SZNUR”) ma służyć przede...
The turn of the year prompts summaries and reflections on what has passed and what is coming. Pointing out the most significant event in the field of pharmaceutical law that took place in 2023 is not difficult: over the past few months, no other law has been as much talked about in the...
Given that the legislative process for a major amendment to the Law on Reimbursement of Medicines, Foodstuffs for Special Dietary Purposes and Medical Devices took a long time (it took more than 2 years from the publication of the first draft to the enactment of the law), the entry of DNUR into...
For weeks, those involved in drug reimbursement (and not only) in Poland have been wondering whether DNUR - a major amendment to the Reimbursement Act - has a chance of being passed yet in this term of the Sejm. The draft of this law was first published on the pages of the Government Legislation...
W kwietniu b.r. Komisja Europejska opublikowała projekt nowej dyrektywy Unii Europejskiej dotyczącej leków stosowanych u ludzi, która miałaby zastąpić obecną dyrektywę 2001/83; a także projekt rozporządzenia unijnego, które zastąpiłoby obecnie obowiązujące rozporządzenie 726/2004 (o...
Representatives of the pharmaceutical industry have long been diligently (and with great concern) following the fate of the draft of a major amendment to the Law on Reimbursement of Medicines, Foodstuffs for Special Dietary Purposes and Medical Devices. The legislative process for this...
Just before the holiday break, on December 21 of last year (already), a draft regulation was sent to public consultations, amending the Regulation of the Minister of Health on the advertising of medicinal products.
© 2023 Medexpress. All Rights Reserved
